Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/ITI-007> ?p ?o }
- ITI-007 abstract "ITI-007 is an investigational atypical antipsychotic which is currently under development by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, for the treatment of schizophrenia. It is also being developed by Intra-Cellular Therapies for the treatment of bipolar disorder, depression, and sleep and behavioral disturbance in dementia, autism, and other neuropsychiatric disorders. As of September 2015, ITI-007 has passed the first of two phase III clinical trials for schizophrenia.".
- ITI-007 iupacName "1-(4-Fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-butanone".
- ITI-007 pubchem "9821941".
- ITI-007 thumbnail ITI-007.svg?width=300.
- ITI-007 wikiPageExternalLink product-pipeline.html.
- ITI-007 wikiPageExternalLink 800026498.
- ITI-007 wikiPageExternalLink iti-007.html.
- ITI-007 wikiPageID "46746893".
- ITI-007 wikiPageLength "11405".
- ITI-007 wikiPageOutDegree "80".
- ITI-007 wikiPageRevisionID "699632131".
- ITI-007 wikiPageWikiLink 5-HT2A_receptor.
- ITI-007 wikiPageWikiLink 5-HT2B_receptor.
- ITI-007 wikiPageWikiLink 5-HT2C_receptor.
- ITI-007 wikiPageWikiLink Akathisia.
- ITI-007 wikiPageWikiLink Alpha-1A_adrenergic_receptor.
- ITI-007 wikiPageWikiLink Alpha-1B_adrenergic_receptor.
- ITI-007 wikiPageWikiLink Aripiprazole.
- ITI-007 wikiPageWikiLink Atypical_antipsychotic.
- ITI-007 wikiPageWikiLink Autism.
- ITI-007 wikiPageWikiLink Bifeprunox.
- ITI-007 wikiPageWikiLink Bipolar_disorder.
- ITI-007 wikiPageWikiLink Blonanserin.
- ITI-007 wikiPageWikiLink Brexpiprazole.
- ITI-007 wikiPageWikiLink Bristol-Myers_Squibb.
- ITI-007 wikiPageWikiLink Cardiovascular_disease.
- ITI-007 wikiPageWikiLink Cardiovascular_physiology.
- ITI-007 wikiPageWikiLink Cariprazine.
- ITI-007 wikiPageWikiLink Catalepsy.
- ITI-007 wikiPageWikiLink Category:5-HT2A_antagonists.
- ITI-007 wikiPageWikiLink Category:Atypical_antipsychotics.
- ITI-007 wikiPageWikiLink Category:D2-receptor_agonists.
- ITI-007 wikiPageWikiLink Category:D2_antagonists.
- ITI-007 wikiPageWikiLink Category:Organofluorides.
- ITI-007 wikiPageWikiLink Category:Quinoxalines.
- ITI-007 wikiPageWikiLink Category:Serotonin_reuptake_inhibitors.
- ITI-007 wikiPageWikiLink Chemical_synapse.
- ITI-007 wikiPageWikiLink Cholesterol.
- ITI-007 wikiPageWikiLink Clinical_trial.
- ITI-007 wikiPageWikiLink Comorbidity.
- ITI-007 wikiPageWikiLink Dementia.
- ITI-007 wikiPageWikiLink Depression_(mood).
- ITI-007 wikiPageWikiLink Diabetes_mellitus.
- ITI-007 wikiPageWikiLink Dopamine.
- ITI-007 wikiPageWikiLink Dopamine_receptor_D1.
- ITI-007 wikiPageWikiLink Dopamine_receptor_D2.
- ITI-007 wikiPageWikiLink Dopamine_receptor_D4.
- ITI-007 wikiPageWikiLink Drug-induced_QT_prolongation.
- ITI-007 wikiPageWikiLink Emotional_and_behavioral_disorders.
- ITI-007 wikiPageWikiLink Extrapyramidal_symptoms.
- ITI-007 wikiPageWikiLink Glucose.
- ITI-007 wikiPageWikiLink Haloperidol.
- ITI-007 wikiPageWikiLink Heart_rate.
- ITI-007 wikiPageWikiLink Histamine_H1_receptor.
- ITI-007 wikiPageWikiLink Insulin.
- ITI-007 wikiPageWikiLink Intra-Cellular_Therapies.
- ITI-007 wikiPageWikiLink Ligand_(biochemistry).
- ITI-007 wikiPageWikiLink Lurasidone.
- ITI-007 wikiPageWikiLink Major_depressive_disorder.
- ITI-007 wikiPageWikiLink Mechanism_of_action.
- ITI-007 wikiPageWikiLink Mental_disorder.
- ITI-007 wikiPageWikiLink Metabolism.
- ITI-007 wikiPageWikiLink Muscarinic_acetylcholine_receptor.
- ITI-007 wikiPageWikiLink Neurotransmission.
- ITI-007 wikiPageWikiLink Olanzapine.
- ITI-007 wikiPageWikiLink Partial_agonist.
- ITI-007 wikiPageWikiLink Pharmacovigilance.
- ITI-007 wikiPageWikiLink Phases_of_clinical_research.
- ITI-007 wikiPageWikiLink Placebo.
- ITI-007 wikiPageWikiLink Prolactin.
- ITI-007 wikiPageWikiLink Psychosis.
- ITI-007 wikiPageWikiLink RP5063.
- ITI-007 wikiPageWikiLink Receptor_antagonist.
- ITI-007 wikiPageWikiLink Risperidone.
- ITI-007 wikiPageWikiLink Schizophrenia.
- ITI-007 wikiPageWikiLink Sedation.
- ITI-007 wikiPageWikiLink Serotonin_reuptake_inhibitor.
- ITI-007 wikiPageWikiLink Serotonin_transporter.
- ITI-007 wikiPageWikiLink Sleep_disorder.
- ITI-007 wikiPageWikiLink Somnolence.
- ITI-007 wikiPageWikiLink Striatum.
- ITI-007 wikiPageWikiLink Structural_functionalism.
- ITI-007 wikiPageWikiLink Suicidal_ideation.
- ITI-007 wikiPageWikiLink Suicide.
- ITI-007 wikiPageWikiLink Tolerability.
- ITI-007 wikiPageWikiLink Triglyceride.
- ITI-007 wikiPageWikiLink Weight_gain.
- ITI-007 wikiPageWikiLinkText "ITI-007".
- ITI-007 c "24".
- ITI-007 chemspiderid "7997690".
- ITI-007 f "1".
- ITI-007 h "28".
- ITI-007 iupacName "1".
- ITI-007 molecularWeight "393.496".
- ITI-007 n "3".
- ITI-007 o "1".
- ITI-007 pubchem "9821941".
- ITI-007 smiles "c3ccccc3CCCCN5CC2CN1CCNc4c1c2ccc4".
- ITI-007 width "290".
- ITI-007 wikiPageUsesTemplate Template:Antipsychotics.